Authors
Latest:
Expert Panel Offers Guidance on Testing for COVID-19, Influenza, RSV During Respiratory Virus Season 2023-2024As flu season approaches this year, experts stress that it's not just about influenza anymore; they discuss testing, antiviral treatment, and management of coinfection.
Latest:
Clinical Implications of Off Target TSH Levels and Importance of Patient Education in Managing HypothyroidismEndocrinology experts discuss the clinical implications of off-target TSH levels and stress the importance of stabilizing these levels for hypothyroidism management.
Latest:
Take-home Messages for Acute Pain ManagementBenjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Latest:
It's High Time to Normalize Pre-Visit Lab TestingResearch demonstrates that discussing test results face-to-face with patients during office visits is beneficial for patient and clinician, according to family physician Andrew Carroll, MD.
Latest:
Why is Wound Care Falling to Primary Care?Overscheduled and undertrained, primary care clinicians shoulder a significant portion of the US wound care burden. Author Nima Ahmadi offers a technology-based solution.
Latest:
Obesity and the Musculoskeletal System: Age and ImpactExcess weight diminishes the development and function of the musculoskeletal system at any point in the lifespan. An obesity specialist highlights the dangers.
Latest:
Milvexian, FXIa Inhibitor, Wins US FDA Fast Track Designation for 3 Indications in Phase 3 Trial ProgramProposed indications for the investigational factor XIa inhibitor are: stroke prevention after acute ischemic stroke or high-risk transient ischemic attack; recent acute coronary syndrome; and atrial fibrillation.
Latest:
Hey Doc: Use or Lose those Vacation DaysVacation behavior among US physicians was found wanting, with more than half taking less than 15 days/year, 20% taking ≤5 days, and 70% working on their time off.
Latest:
Semaglutide Cuts Cardiovascular Risk by 20% in Adults with Obesity, CVD and Without DiabetesAHA 2023: Semaglutide 2.4 mg reduced the risk of serious cardiovascular events by 20% in patients with obesity and overweight with established CVD but without diabetes, according to full SELECT trialresults.
Latest:
Lung Cancer Survival Improved Significantly Based on Early CT Screening: 20-Year Follow-Up Study FindingsEarly CT screening led to a 20-year lung cancer survival rate of 81% in the International Early Lung Cancer Action Program. Details, here.
Latest:
Practice Pearls for Optimizing MDD TreatmentGreg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, provide their practice pearls for community psychiatrists and psychiatric nurse practitioners who care for patients with major depressive disorder (MDD) to optimize their treatment and management.
Latest:
Final Thoughts on Treatment of AsthmaRaffi Tachdjian, MD, MPH, FAAAAI, FACAAI; Dareen D. Siri, MD, FAAAAI, FACAAI; Nicole Chase, MD, FAAP, FACAAI, FAAAAI; and Andrew White, MD, give final thoughts on asthma management, considering the current treatment landscape.
Latest:
Flu Vaccination for Children May Reduce Hospitalization for RSV, Suggest New DataThe influenza vaccine may offer a protective effect against hospitalization for respiratory syncytial virus in young children, suggest data from Australia.
Latest:
Dosing Strategy and Final Pearls for Nirsevimab for RSVExperts conclude their discussion on the efficacy and safety study of nirsevimab for Respiratory Syncytial Virus (RSV) commenting on possible dosing strategies and key takeaways from this study.
Latest:
Nirsevimab-alip Gets Unanimous ACIP Recommendation to Prevent RSV in Neonates, InfantsThe ACIP was unanimous in its recommendation for routine use of nirsevimab-alip to prevent RSV LRTD in newborns and young infants during their first RSV season.
Latest:
Q&A: Diabetic Retinopathy Screening Devices and TechnologiesWade Brosius, DO, Shelton Hager, MD, and Steven Peskin, MD, answer questions relating to diabetic retinopathy screening devices and highlight novel technologies utilized in this space.
Latest:
Obesity: How Can America Afford to Treat the Disease?While incretin-based antiobesity medications are the optimal treatment for some, there are other less costly approaches that can support weight loss success, this author says.
Latest:
Vaccine Clinic: If Abuelo Could See Me NowAs a second-year medical student volunteers at a COVID-19 vaccine clinic, the Spanish last name shared by the elderly couple now in front of her is a poignant reminder of why she chose medicine.
Latest:
Final Thoughts on Treatment of AsthmaRaffi Tachdjian, MD, MPH, FAAAAI, FACAAI; Dareen D. Siri, MD, FAAAAI, FACAAI; Nicole Chase, MD, FAAP, FACAAI, FAAAAI; and Andrew White, MD, give final thoughts on asthma management, considering the current treatment landscape.
Latest:
Learning that Health Care is a PrivilegeA young medical student, native of Peru and now resident of Georgia in the US, relates her early education in health care disparities, first in Peru, then in her adopted home.
Latest:
Insulin Prescription Fills Up Following Inflation Reduction Act Cap on Out-of-Pocket CostsThe new policy is helping people who are taking insulin save money and helping others to afford it in the first place, says a study coauthor from the USC Sol Price School of Public Policy .
Latest:
Fact vs Fiction in Alzheimer DiseaseNovember is Alzheimer Awareness Month and a good time to look at common myths held by clinicians and patients alike - and the facts to refute them.
Latest:
Improved Diabetes and Kidney Function Control With KidneyIntelXDrs Aide Vega and Fernando Carnavali highlight the increased control in both diabetes and kidney function with the use of KidneyIntelX in patients with DKD.
Latest:
Risk Stratification for Preeclampsia Would Save Lives, Reduce Burden of Cost to Health Care SystemIdentifying women at risk for preeclampsia with severe features and the most effective treatment is essential to reduce morbidity as well as to contain costs.
Latest:
Final Thoughts on Treatment of AsthmaRaffi Tachdjian, MD, MPH, FAAAAI, FACAAI; Dareen D. Siri, MD, FAAAAI, FACAAI; Nicole Chase, MD, FAAP, FACAAI, FAAAAI; and Andrew White, MD, give final thoughts on asthma management, considering the current treatment landscape.
Latest:
Final Thoughts on Treatment of AsthmaRaffi Tachdjian, MD, MPH, FAAAAI, FACAAI; Dareen D. Siri, MD, FAAAAI, FACAAI; Nicole Chase, MD, FAAP, FACAAI, FAAAAI; and Andrew White, MD, give final thoughts on asthma management, considering the current treatment landscape.
Latest:
Pediatric EoE: FDA Accepts Dupilumab sBLA for Priority Review in Children Younger than 12 YearsDupilumab, a monoclonal antibody targeting type 2 inflammation, would be the first treatment of its kind for younger children with eosinophilic esophagitis.
Latest:
Take-home Messages for Acute Pain ManagementBenjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Latest:
The 10 Best States for PhysiciansSome states that are better for physicians than others in terms of finances, competition, and other criteria. Partner site Physicians Practice crunched the numbers for you.
